SYSTEMATIC FINANCIAL MANAGEMENT LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
SYSTEMATIC FINANCIAL MANAGEMENT LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$297,000
-50.5%
4,080
-29.0%
0.02%
-21.7%
Q4 2019$600,000
+4.9%
5,7500.0%0.02%
-11.5%
Q3 2019$572,000
-40.4%
5,750
-31.5%
0.03%
-29.7%
Q2 2019$959,000
-25.8%
8,400
-18.2%
0.04%
-15.9%
Q1 2019$1,292,00010,2750.04%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders